“CSL delivered a solid result for the first half of the 2025 financial year led by CSL Behring. Strong demand for many of our market-leading therapies has translated into sales growth, particularly in ...

Guggenheim Securities adjusted its price target for Immunovant shares, listed on (NASDAQ:IMVT), to $44.00, a decrease from the previous $46.00, while sustaining a Buy rating on the stock. Currently ...

H.C. Wainwright reaffirmed their Buy rating on Immunovant (NASDAQ:IMVT) shares with a price target of $51.00, aligning with the broader Wall Street sentiment. According to InvestingPro data, analyst ...

Albert Fiori was diagnosed with Chronic Inflammatory Demyelinating Polyneuropathy or CIDP, a rare autoimmune disease that affects his eye, one arm and one leg. But he is not letting that stop him from ...

THE family of a "beloved father and husband" who took his own life after Covid-19 vaccine complications are fighting for justice.

Background: Chronic liver diseases (CLD) continue to pose a significant global burden, potentially exacerbated by pro-inflammatory diets. This study explores the relationship between the Dietary ...

Patients with COVID-19 who developed chronic inflammatory demyelinating polyneuropathy (CIDP) as a complication could follow a specific pattern in medical management, according to a study published in ...

Critical illness polyneuropathy (CIP ... basic pathophysiology of both disorders is complex and involves metabolic, inflammatory and bioenergetic alterations. It is unclear at present whether ...

Jaimie Sheil, from Melbourne, Australia, was diagnosed with chronic inflammatory demyelinating polyneuropathy (CIDP) when she was 23 years old. Prior to her illness, she was a PhD student studying ...